Biotechnology - Singapore firm abandons plans for stem cell therapies

被引：5
|
作者：
Normile, Dennis
机构：
来源：
SCIENCE | 2007年 / 317卷 / 5836期
关键词：
D O I：
10.1126/science.317.5836.305
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
A firm in Singapore has halted work on human embryonic stem cell therapies. The company was attempting to turn hES cells into insulin-producing cells to treat diabetes and cardiac muscle cells to counter congestive heart failure. The laboratory will now focus on providing hES cells and derived cells for basic research and drug development.
引用
收藏
页码：305 / 305
页数：1
相关论文
共 50 条
  • [1] Chinese firm abandons plans to bid for Thai petrochemical industry
    Young, I
    CHEMICAL WEEK, 2005, 167 (23) : 21 - 21
  • [2] Advancements in Biotechnology and Stem Cell Therapies for Breast Cancer Patients
    Dhoundiyal, Shivang
    Alam, Md Aftab
    CURRENT STEM CELL RESEARCH & THERAPY, 2024, 19 (08) : 1072 - 1083
  • [3] Stem Cell Biotechnology
    Vaishali, Dixit
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2010, 5 (04): : 3 - 4
  • [4] Stem cell research in Singapore
    Colman, Alan
    CELL, 2008, 132 (04) : 519 - 521
  • [5] BIOTECHNOLOGY Fujifilm plans cell culture media in Europe
    Mullin, Rick
    CHEMICAL & ENGINEERING NEWS, 2019, 97 (28) : 15 - 15
  • [6] Stem cell scientist moves to Singapore
    Karen Birmingham
    Nature Medicine, 2002, 8 : 314 - 314
  • [7] Stem cell scientist moves to Singapore
    Birmingham, K
    NATURE MEDICINE, 2002, 8 (04) : 314 - 314
  • [8] Unlikely stem cell therapies
    Condic, Maureen
    NATURE NEUROSCIENCE, 2007, 10 (07) : 803 - 803
  • [9] Gene and stem cell therapies
    Kaji, EH
    Leiden, JM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (05): : 545 - 550
  • [10] Stem cell therapies in the clinic
    Acharya, Shrinivas
    Shaha, Suyog
    Bibbey, Michael Griffith
    Mukherji, Malini
    Zhao, Zongmin
    Mitragotri, Samir
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2025,
12345